Abstract:Background: Offspring exposed to gestational diabetes mellitus (GDM) are at a high risk for metabolic diseases. The mechanisms behind the association between offspring exposed to GDM in utero and an increased risk of health consequences later in life remain unclear. The aim of this study was to clarify the changes in methylation levels in the foetuses of women with GDM and to explore the possible mechanisms linking maternal GDM with a high risk of metabolic diseases in offspring later in life. Methods: A genome-wide comparative methylome analysis on the umbilical cord blood of infants born to 30 women with GDM and 33 women with normal pregnancy was performed using Infinium HumanMethylation 450 BeadChip assays. A quantitative methylation analysis of 18 CpG dinucleotides was verified in the validation umbilical cord blood samples from 102 newborns exposed to GDM and 103 newborns who experienced normal pregnancy by MassARRAY EpiTYPER. Results: A total of 4485 differentially methylated sites (DMSs), including 2150 hypermethylated sites and 2335 hypomethylated sites, with a mean beta-value difference of >0.05, were identified by the 450k array. Good agreement was observed between the massarray validation data and the 450k array data (R-2 > 0.99; P < 0.0001). Thirty-seven CpGs (representing 20 genes) with a b-value difference of > 0.15 between the GDM and healthy groups were identified and showed potential as clinical biomarkers for GDM. "hsa04940: Type I diabetes mellitus" was the most significant Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway, with a P-value = 3.20E-07 and 1.36E-02 in the hypermethylated and hypomethylated genepathway enrichment analyses, respectively. In the Gene Ontology (GO) pathway analyses, immune MHC (major histocompatibility complex)-related pathways and neuron development-related pathways were significantly enriched. Conclusions: Our results suggest that GDM has epigenetic effects on genes that are preferentially involved in the Type I diabetes mellitus pathway, immune MHC-related pathways and neuron development-related pathways, with consequences on fetal growth and development, and provide supportive evidence that DNA methylation is involved in fetal metabolic programming. (C) 2018 Elsevier B.V. All rights reserved.

Gestational diabetes mellitus is associated with the neonatal gut microbiota and metabolome

Diversified Gut Microbiota In Newborns Of Mothers With Gestational Diabetes Mellitus

Dysbiosis of Maternal and Neonatal Microbiota Associated with Gestational Diabetes Mellitus.

Landscapes of maternal and neonatal gut microbiome and plasma metabolome signatures and their interaction in gestational diabetes mellitus

Genome-wide DNA Methylation Profiling in Infants Born to Gestational Diabetes Mellitus

Newborn meconium and urinary metabolome response to maternal gestational diabetes mellitus: a preliminary case-control study

Altered gut bacterial and metabolic signatures and their interaction in gestational diabetes mellitus

The Association Between Gestational Diabetes and Microbiota in Placenta and Cord Blood

Association of Gestational Diabetes With the Dynamic Changes of Gut Microbiota in Offspring From 1 to 6 Months of Age

Gestational diabetes exacerbates intrauterine microbial exposure induced intestinal microbiota change in offspring contributing to increased immune response

The Intestinal Dysbiosis of Mothers with Gestational Diabetes Mellitus (GDM) and Its Impact on the Gut Microbiota of Their Newborns

Maternal gestational diabetes mellitus associates with altered gut microbiome composition and head circumference abnormalities in male offspring

The Association between Gut Microbiota and Its Metabolites in Gestational Diabetes Mellitus

The Gut Microbial Signature of Gestational Diabetes Mellitus and the Association With Diet Intervention

Alterations of gut microbiota-derived metabolites in gestational diabetes mellitus and clinical significance

Increased Methylation at Differentially Methylated Region of GNASin Infants Born to Gestational Diabetes

Gestational Diabetes Mellitus Changes the Metabolomes of Human Colostrum, Transition Milk and Mature Milk.

Gut microbiome interacts with pregnancy hormone metabolites in gestational diabetes mellitus

Multiple Elements Related to Metabolic Markers in the Context of Gestational Diabetes Mellitus in Meconium.

Gestational diabetes-combined excess weight gain exacerbates gut microbiota dysbiosis in newborns, associated with reduced abundance of Clostridium, Coriobacteriaceae, and Collinsella

Integrative metagenomic and metabolomic analyses reveal gut microbiota-derived multiple hits connected to development of gestational diabetes mellitus in humans